Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
Merz Therapeutics’ $185m Acquisition of Acorda Therapeutics
Grünenthal’s EUR 500 Million Acquisition of Bayer’s Nebido™
Allen & Overy advised Bayer AG on the deal. Freshfields Bruckhaus Deringer advised Grünenthal. Bayer AG sold its men’s health product Nebido™ (testosterone undecanoate) to Grünenthal...